Citadel Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$605K Sell
220,700
-131,000
-37% -$415K ﹤0.01% 8833
2025
Q4
$1.3M Buy
351,700
+266,100
+311% +$860K ﹤0.01% 6831
2025
Q3
$227K Buy
85,600
+57,700
+207% +$112K ﹤0.01% 10987
2025
Q2
$27.5K Sell
27,900
-72,900
-72% -$73K ﹤0.01% 12015
2025
Q1
$145K Buy
100,800
+63,100
+167% +$116K ﹤0.01% 10928
2024
Q4
$82.9K Sell
37,700
-35,000
-48% -$81.7K ﹤0.01% 11744
2024
Q3
$120K Buy
72,700
+31,600
+77% +$63.8K ﹤0.01% 10882
2024
Q2
$91.2K Sell
41,100
-106,400
-72% -$250K ﹤0.01% 11047
2024
Q1
$395K Buy
147,500
+85,300
+137% +$207K ﹤0.01% 8880
2023
Q4
$186K Buy
62,200
+8,300
+15% +$10.8K ﹤0.01% 10057
2023
Q3
$52.8K Sell
53,900
-104,500
-66% -$151K ﹤0.01% 11698
2023
Q2
$220K Sell
158,400
-27,200
-15% -$38K ﹤0.01% 9676
2023
Q1
$295K Sell
185,600
-226,500
-55% -$1.17M ﹤0.01% 9409
2022
Q4
$2.57M Buy
412,100
+202,500
+97% +$1.45M ﹤0.01% 5019
2022
Q3
$1.4M Buy
209,600
+51,900
+33% +$356K ﹤0.01% 6287
2022
Q2
$1M Buy
157,700
+30,700
+24% +$174K ﹤0.01% 7001
2022
Q1
$589K Sell
127,000
-39,000
-23% -$167K ﹤0.01% 8994
2021
Q4
$830K Buy
166,000
+89,000
+116% +$713K ﹤0.01% 8396
2021
Q3
$928K Buy
77,000
+49,700
+182% +$724K ﹤0.01% 8341
2021
Q2
$577K Sell
27,300
-26,400
-49% -$636K ﹤0.01% 9731
2021
Q1
$1.51M Sell
53,700
-42,100
-44% -$1.24M ﹤0.01% 7090
2020
Q4
$2.49M Sell
95,800
-3,100
-3% -$92.9K ﹤0.01% 4901
2020
Q3
$3.68M Buy
98,900
+12,800
+15% +$507K ﹤0.01% 3629
2020
Q2
$4.42M Buy
86,100
+48,300
+128% +$2.02M ﹤0.01% 3254
2020
Q1
$1.19M Sell
37,800
-26,700
-41% -$1.41M ﹤0.01% 5015
2019
Q4
$3.85M Buy
64,500
+11,800
+22% +$531K ﹤0.01% 3440
2019
Q3
$1.93M Sell
52,700
-36,900
-41% -$1.46M ﹤0.01% 4528
2019
Q2
$4.17M Buy
89,600
+7,700
+9% +$362K ﹤0.01% 3369
2019
Q1
$3.29M Buy
81,900
+42,500
+108% +$1.91M ﹤0.01% 3605
2018
Q4
$1.81M Sell
39,400
-12,800
-25% -$617K ﹤0.01% 4298
2018
Q3
$2.32M Sell
52,200
-20,700
-28% -$950K ﹤0.01% 4163
2018
Q2
$2.86M Buy
72,900
+25,700
+54% +$1.3M ﹤0.01% 3556
2018
Q1
$3.41M Buy
47,200
+10,300
+28% +$756K ﹤0.01% 2960
2017
Q4
$2.43M Buy
36,900
+24,200
+191% +$1.3M ﹤0.01% 3361
2017
Q3
$637K Sell
12,700
-15,500
-55% -$747K ﹤0.01% 4974
2017
Q2
$1.3M Sell
28,200
-15,600
-36% -$574K ﹤0.01% 3719
2017
Q1
$1.55M Buy
+43,800
New +$1M ﹤0.01% 3387
2016
Q4
Sell
-18,500
Closed -$256K 7389
2016
Q3
$256K Sell
18,500
-1,900
-9% -$21.5K ﹤0.01% 5936
2016
Q2
$202K Buy
20,400
+4,200
+26% +$69.6K ﹤0.01% 5818
2016
Q1
$274K Buy
16,200
+3,600
+29% +$57.9K ﹤0.01% 5212
2015
Q4
$280K Sell
12,600
-17,100
-58% -$431K ﹤0.01% 5319
2015
Q3
$701K Buy
29,700
+16,800
+130% +$1.05M ﹤0.01% 4300
2015
Q2
$1.05M Sell
12,900
-11,200
-46% -$1.1M ﹤0.01% 3902
2015
Q1
$2.23M Buy
+24,100
New +$1.56M ﹤0.01% 2926

Other funds holding ESPR